CorVel Co. (NASDAQ:CRVL) Director Steven J. Hamerslag sold 3,800 shares of the firm’s stock in a transaction dated Tuesday, June 8th. The shares were sold at an average price of $120.88, for a total value of $459,344.00. Following the completion of the sale, the director now directly owns 120,548 shares in the company, valued at approximately $14,571,842.24. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Shares of NASDAQ CRVL opened at $122.31 on Friday. The stock has a market cap of $2.19 billion, a PE ratio of 47.96 and a beta of 1.00. CorVel Co. has a 1-year low of $62.31 and a 1-year high of $126.90. The firm’s 50-day moving average price is $116.22.
CorVel (NASDAQ:CRVL) last released its quarterly earnings data on Thursday, May 27th. The business services provider reported $0.81 earnings per share (EPS) for the quarter. CorVel had a net margin of 8.39% and a return on equity of 22.32%. The firm had revenue of $145.51 million for the quarter.
CorVel Company Profile
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
Featured Story: Mutual funds are not immune from market timing
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.